Consumer Attitudes & Behavior

A premium long viewed as a financial irritant in British Columbia that is paid by individuals and families for health care will be eliminated on Jan. 1, 2020.

Monoclonal antibodies targeting the calcitonin gene-related peptide pathway are under study for preventing episodic and chronic migraine

A new government report sheds light on the opioid industry's ability to shape public opinion

Over the weekend, Purdue said it eliminated more than half its sales staff this week and will no longer send sales representatives to doctors' offices to discuss opioid drugs